The Impact of Direct-to-Consumer Advertising of Prescription Medications on Healthy Lifestyle

2012 ◽  
Vol 50 (4) ◽  
pp. 103-113 ◽  
Author(s):  
Hae-Kyung Yang
Keyword(s):  
Healthy Lifestyle ◽  
Prescription Medications ◽  
Direct To Consumer ◽  
Direct To Consumer Advertising ◽  
The Impact

The Impact of Industry on Oncology Research and Practice

2015 ◽  
pp. 130-137 ◽  
Author(s):  
Beverly Moy ◽  
Reshma Jagsi ◽  
Richard B. Gaynor ◽  
Mark J. Ratain
Keyword(s):  
Conflicts Of Interest ◽  
Ethical Challenges ◽  
Patients With Cancer ◽  
Direct To Consumer ◽  
Professional Societies ◽  
Oncology Research ◽  
Public Scrutiny ◽  
Oncology Practice ◽  
Direct To Consumer Advertising ◽  
The Impact

Public scrutiny has increased over potential conflicts of interest among oncology researchers and providers. Given the increased prevalence and complexity of industry relationships, oncologists are increasingly faced with ethical challenges when navigating their financial relationships with industry. Oncologists are continually dealing with changing conflict of interest policies within academic centers and professional societies. With the recent passage of The Sunshine Act, oncologists are beginning to understand the repercussions of this new law. The consequences of the increasing use of direct-to-consumer advertising on patients with cancer are also unclear. Finally, industry's perspective on the evolution of these relationships is not clearly understood. This manuscript discusses issues related to industry's influence on oncology practice and research.

Sign in / Sign up

Export Citation Format

Share Document